Live Quote · OTCACMSYHealthcare· Medical - Diagnostics & Research

AccuStem Sciences Limited

$0.13 7.14%($-0.01)
TickerSpark Score
45/100
Weak
73
Valuation
40
Profitability
40
Growth
40
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACMSY research report →

52-Week Range22% of range
Low
$0.01
Current
$0.13
High
$0.56
Company Overviewwww.accustem.com

About the company

AccuStem Sciences Limited, founded in 2020 and headquartered in London, United Kingdom, focuses on providing diagnostic assays that utilize genomic signatures. These tests are developed to forecast the probability of both short-term and long-term relapse of ER+/HER2 breast cancer in individuals with an early-stage diagnosis.

IPO
2021
HQ
London, GB

Price Chart

-18.75% · this period
$0.25$0.17$0.10Jan 03Feb 10Apr 24
Valuation
Market Cap
$0
P/E
-0.00
P/S
0.00
P/B
-0.54
EV/EBITDA
0.01
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
55226.46%
ROIC
45350.84%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-1,756,096,000 · -116584.12%
EPS
$-0.12 · 7.69%
Op Income
$-1,756,096,000
FCF YoY
-127957.90%
Performance & Tape
52W High
$0.56
52W Low
$0.01
50D MA
$0.14
200D MA
$0.23
Beta
0.00
Avg Volume
18.16K

Get TickerSpark's AI analysis on ACMSY

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 13, 25CERRONE GABRIELE Mbuy400
Jun 13, 25CERRONE GABRIELE Mbuy2,000
Jun 12, 25CERRONE GABRIELE Mbuy8,991
Jun 11, 25CERRONE GABRIELE Mbuy28,205
Apr 9, 25CERRONE GABRIELE Mbuy3,000
Apr 8, 25CERRONE GABRIELE Mbuy35,000
Apr 7, 25CERRONE GABRIELE Mbuy35,000
Apr 7, 25CERRONE GABRIELE Mbuy17,802
Mar 18, 25CERRONE GABRIELE Mbuy100,000
Dec 31, 24CERRONE GABRIELE Mbuy100,000
Coverage · ACMSY

Our ACMSY coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on ACMSY yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate ACMSY report →